PT-141

PT-141, also known as Bremelanotide, is a research-grade synthetic cyclic heptapeptide derived as a metabolite of Melanotan II. It functions as a non-selective melanocortin receptor agonist with particular affinity for MC3R and MC4R subtypes. Unlike vasoactive compounds that act peripherally, PT-141 operates centrally via the nervous system, making it a unique reference compound for studying neuroendocrine and central arousal pathways at the receptor level.

Available in 10mg vials. Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.

Research applications include:

• Melanocortin receptor (MC1R–MC5R) agonism and binding kinetics studies
• Central nervous system arousal signalling research models
• Neuroendocrine function and hypothalamic pathway investigation
• Peptide-mediated mood and behaviour modulation mechanism studies
• Comparative research vs PDE5 inhibitors and peripheral vasoactive compounds
• α-MSH analogue and pigmentation pathway research

Product specifications:

• Form: Lyophilised powder
• Purity: ≥99% (HPLC verified)
• Storage: −20°C, protected from light and moisture
• Available size: 10mg
• Origin: UK warehouse, same day dispatch